Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.
暂无分享,去创建一个
[1] R. Zinkernagel,et al. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.
[2] J. Klein,et al. Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness , 1978, The Journal of experimental medicine.
[3] J. Bennink,et al. Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype , 1978, The Journal of experimental medicine.
[4] J. Bennink,et al. The response to H-2-different virus-infected cells is mediated by long-lived T lymphocytes and is diminished by prior virus priming in a syngeneic environment. , 1981, Cellular immunology.
[5] J. Davey,et al. Cytotoxic T cells recognize fragments of the influenza nucleoprotein , 1985, Cell.
[6] B. Coupar,et al. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response , 1986, European journal of immunology.
[7] A. McMichael,et al. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides , 1986, Cell.
[8] B. Moss,et al. Anti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein: responsiveness to individual viral antigens is major histocompatibility complex controlled , 1987, Journal of virology.
[9] B. Moss,et al. Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes , 1987, The Journal of experimental medicine.
[10] R. Ahmed,et al. T cell memory. Long-term persistence of virus-specific cytotoxic T cells , 1989, The Journal of experimental medicine.
[11] W. Britt,et al. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. , 1991, Journal of immunology.
[12] H. Rammensee,et al. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast , 1991, The Journal of experimental medicine.
[13] V. Engelhard,et al. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein. , 1991, Journal of immunology.
[14] P. Srivastava,et al. Tumor-specific immunogenicity of stress-induced proteins: convergence of two evolutionary pathways of antigen presentation? , 1991, Seminars in immunology.
[15] U. Koszinowski,et al. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein , 1991, Cell.
[16] P. Srivastava,et al. Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation. , 1993, Advances in cancer research.
[17] A. Miller,et al. Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.
[18] D. Rowley,et al. A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens , 1993, The Journal of experimental medicine.
[19] D. Rowley,et al. A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens , 1993, The Journal of experimental medicine.
[20] M. Eichelberger,et al. Prominent usage of V beta 8.3 T cells in the H-2Db-restricted response to an influenza A virus nucleoprotein epitope. , 1993, Journal of immunology.
[21] V. Engelhard. Structure of peptides associated with MHC class I molecules. , 1994, Current opinion in immunology.
[22] K. Parker,et al. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.
[23] E. Pamer,et al. Efficiency of MHC class I antigen processing: a quantitative analysis. , 1994, Immunity.
[24] A. Vitiello,et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. , 1994, Journal of immunology.
[25] B. Walker,et al. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire , 1994, The Journal of experimental medicine.
[26] T. Braciale,et al. Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes , 1994, The Journal of experimental medicine.
[27] M. Bevan,et al. Major histocompatibility complex class I allele‐specific peptide libraries: Identification of peptides that mimic an H‐Y T cell epitope , 1994, European journal of immunology.
[28] R. Young,et al. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 , 1994, The Journal of experimental medicine.
[29] D. Margulies,et al. Determinant selection of major histocompatibility complex class I- restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues , 1994, The Journal of experimental medicine.
[30] J. Sidney,et al. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. , 1994, Molecular immunology.
[31] J. Burrows,et al. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease , 1994, The Journal of experimental medicine.
[32] M. Oldstone,et al. T-cell receptors from virus-specific cytotoxic T lymphocytes recognizing a single immunodominant nine-amino-acid viral epitope show marked diversity , 1994, Journal of virology.
[33] V. Engelhard,et al. Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice. , 1994, Journal of immunology.
[34] M. Nerenberg,et al. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus , 1994, The Journal of experimental medicine.
[35] M. Bevan,et al. Antigen presentation to cytotoxic T lymphocytes in vivo , 1995, The Journal of experimental medicine.
[36] R. J. Cohen,et al. The law of mass action governs antigen-stimulated cytolytic activity of CD8+ cytotoxic T lymphocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[37] A. McMichael,et al. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised , 1995, The Journal of experimental medicine.
[38] P. A. Peterson,et al. Human CD8 transgene regulation of HLA recognition by murine T cells , 1995, The Journal of experimental medicine.
[39] S. Kienle,et al. Decrypting the structure of major histocompatibility complex class I- restricted cytotoxic T lymphocyte epitopes with complex peptide libraries , 1995, The Journal of experimental medicine.
[40] K Eichmann,et al. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. , 1995, Immunity.
[41] M. V. von Herrath,et al. CTL escape viral variants. II. Biologic activity in vivo. , 1995, Virology.
[42] M. Feltkamp,et al. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. , 1995, Journal of immunology.
[43] D. Madden. The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.
[44] Mark M. Davis,et al. T‐Cell Receptor V‐Region Usage and Antigen Specificity , 1995, Annals of the New York Academy of Sciences.
[45] J. Sun,et al. Interaction between CD8 and major histocompatibility complex (MHC) class I mediated by multiple contact surfaces that include the alpha 2 and alpha 3 domains of MHC class I , 1995, The Journal of experimental medicine.
[46] V. Engelhard,et al. Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice. , 1995, International immunology.
[47] R. Anderson,et al. Antigen processing in vivo and the elicitation of primary CTL responses. , 1995, Journal of immunology.
[48] A. Fauci,et al. New concepts in the immunopathogenesis of HIV infection. , 1995, Annual review of immunology.
[49] J. Lippolis,et al. Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen , 1995, Journal of virology.
[50] H. Eisen,et al. Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses. , 1995, Journal of immunology.
[51] S. Rowland-Jones,et al. Different MHC class I alleles compete for presentation of overlapping viral epitopes. , 1995, Immunity.
[52] J. Berzofsky,et al. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. , 1995, Journal of immunology.
[53] S. L. Silins,et al. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen , 1995, The Journal of experimental medicine.
[54] C. Melief,et al. The rat cim effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER. , 1996, Immunity.
[55] P. S. Andersen,et al. A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[56] T. Braciale,et al. The weak CD8+ CTL response to an influenza hemagglutinin epitope reflects limited T cell availability. , 1996, Journal of immunology.
[57] C V Jongeneel,et al. Single-cell PCR analysis of TCR repertoires selected by antigen in vivo: a high magnitude CD8 response is comprised of very few clones. , 1996, Immunity.
[58] D. Valmori,et al. Immunodominance of cytotoxic T lymphocyte epitopes co‐injected in vivo and modulation by interleukin‐12 , 1996, European journal of immunology.
[59] A. Vitiello,et al. Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes. , 1996, Journal of immunology.
[60] Lieping Chen,et al. B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes , 1996, The Journal of experimental medicine.
[61] J. Sidney,et al. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. , 1996, Journal of immunology.
[62] J. Goedert,et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.
[63] S. L. Silins,et al. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis , 1996, The Journal of experimental medicine.
[64] H. Eisen,et al. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. , 1996, Immunity.
[65] A. Rickinson,et al. Epitope focusing in the primary cytotoxic T cell response to Epstein- Barr virus and its relationship to T cell memory , 1996, The Journal of experimental medicine.
[66] C. Hahn,et al. Endogenous presentation of a nascent antigenic epitope to CD8+ CTL is more efficient than exogenous presentation , 1996, Immunology and cell biology.
[67] Søren Buus,et al. Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding , 1996, European journal of immunology.
[68] V. Levitsky,et al. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4 , 1996, The Journal of experimental medicine.
[69] H. Grey,et al. Antigen analogs as tools to study T-cell activation function and activation. , 1996, Seminars in immunology.
[70] A. Vitiello,et al. Differences and similarities in the A2.1‐restricted cytotoxic T cell repertoire in humans and human leukocyte antigen‐transgenic mice , 1996, European journal of immunology.
[71] A. Rickinson,et al. Cytotoxic T lymphocyte responses to Epstein-Barr virus. , 1996, Current opinion in immunology.
[72] C. Waes,et al. Immunodominant deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro , 1996 .
[73] P M Kloetzel,et al. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. , 1996, Immunity.
[74] S. H. van der Burg,et al. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. , 1996, Journal of immunology.
[75] J. Bell,et al. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis , 1996, Nature Medicine.
[76] P. Allen,et al. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. , 1996, Annual review of immunology.
[77] J. Manuguerra,et al. Protection against lethal viral infection by vaccination with nonimmunodominant peptides. , 1996, Journal of immunology.
[78] X. Jin,et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL , 1996, Journal of virology.
[79] J. Reimann,et al. MHC class I-restricted CTL responses to exogenous antigens. , 1996, Immunity.
[80] J. Sidney,et al. Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes. , 1997, Journal of immunology.
[81] V. Levitsky,et al. Epitope-dependent Selection of Highly Restricted or Diverse T Cell Receptor Repertoires in Response to Persistent Infection by Epstein-Barr Virus , 1997, The Journal of experimental medicine.
[82] C. Perreault,et al. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens , 1997, European journal of immunology.
[83] L. Eisenlohr,et al. Murine Transporter Associated with Antigen Presentation (TAP) Preferences Influence Class I–restricted T Cell Responses , 1997, The Journal of experimental medicine.
[84] A. Agulnik,et al. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. , 1997, Immunity.
[85] D. Moss,et al. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. , 1997, Annual review of immunology.
[86] N. Tanahashi,et al. Proteasomes and antigen processing. , 1997, Advances in immunology.
[87] T. Elliott,et al. Transporter associated with antigen processing. , 1997, Advances in immunology.
[88] Hans-Georg Rammensee,et al. MHC Ligands and Peptide Motifs , 1998, Molecular Biology Intelligence Unit.
[89] J. Yewdell,et al. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. , 1997, Immunity.
[90] F. Carbone,et al. Evidence for cooperation between TCR V region and junctional sequences in determining a dominant cytotoxic T lymphocyte response to herpes simplex virus glycoprotein B. , 1997, International immunology.
[91] T. Hogg,et al. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection. , 1997, Journal of immunology.
[92] J. Ulmer,et al. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization , 1997, Journal of virology.
[93] R. Siliciano,et al. Targeting of HIV-1 Antigens for Rapid Intracellular Degradation Enhances Cytotoxic T Lymphocyte (CTL) Recognition and the Induction of De Novo CTL Responses In Vivo After Immunization , 1997, The Journal of experimental medicine.
[94] E. Wherry,et al. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein. , 1997, Journal of immunology.
[95] U. Hellman,et al. Cloning and functional characterization of a subunit of the transporter associated with antigen processing. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[96] J. Sidney,et al. Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice , 1997, Journal of virology.
[97] J. Yewdell,et al. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. , 1997, Journal of immunology.
[98] J. Yewdell,et al. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. , 1997, Journal of immunology.
[99] E. Pamer,et al. Immunodominant and subdominant CTL responses to Listeria monocytogenes infection. , 1997, Journal of immunology.
[100] K. Smith,et al. Cytotoxic CD8+ T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts: immunodominance is elicited by a peptide epitope that is presented at low levels in vitro. , 1997, Journal of immunology.
[101] S. Rowland-Jones,et al. Role of cellular immunity in protection against HIV infection. , 1997, Advances in immunology.
[102] U. Utz,et al. Analysis of the Expression of Peptide–Major Histocompatibility Complexes Using High Affinity Soluble Divalent T Cell Receptors , 1997, The Journal of experimental medicine.
[103] W. Deppert,et al. References Subscriptions Permissions Email Alerts Relationship Among Immunodominance of Single , 2013 .
[104] D. Busch,et al. MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL. , 1998, Journal of immunology.
[105] R. Webster,et al. Induction of CD8+ T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination. , 1998, Journal of immunology.
[106] A. McMichael,et al. A New Look at T Cells , 1998, The Journal of experimental medicine.
[107] C Oseroff,et al. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. , 1998, Virology.
[108] P. Grufman,et al. Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery. , 1998, Journal of immunology.
[109] P. Cresswell,et al. Mechanisms of MHC class I--restricted antigen processing. , 1998, Annual review of immunology.
[110] E. Pamer,et al. Effect of antigen-processing efficiency on in vivo T cell response magnitudes. , 1998, Journal of immunology.
[111] D. Busch,et al. Coordinate regulation of complex T cell populations responding to bacterial infection. , 1998, Immunity.
[112] J. Yewdell,et al. An Endoplasmic Reticulum-Targeting Signal Sequence Enhances the Immunogenicity of an Immunorecessive Simian Virus 40 Large T Antigen Cytotoxic T-Lymphocyte Epitope , 1998, Journal of Virology.
[113] D. Rowley,et al. B lymphocytes secreting IgG linked to latent transforming growth factor-beta prevent primary cytolytic T lymphocyte responses. , 1998, International immunology.
[114] F. Momburg,et al. Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules. , 1998, Advances in immunology.